BELANOFF JOSEPH K (Chief Executive Officer) sold 0.5% of their position (12.84K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $895.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/2/2026ACC: 0001193125-26-253459
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-12.84K
Net shares
Net seller
$895.3K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
300K acquired · 312.84K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−300K
Price / share
—
Trade value
—
% of position
10.4%
5/29/2026
2.88M→2.58M
Common Stock
Indirect
Shares
+150K
Price / share
—
Trade value
—
% of position
New position
5/29/2026
0.00→150K
Common Stock
Indirect
Shares
+150K
Price / share
—
Trade value
—
% of position
New position
5/29/2026
0.00→150K
Common Stock
Indirect
Shares
−12.84K
Price / share
$69.74
Trade value
$895.25K
% of position
0.5%
6/1/2026
2.58M→2.57M
Total
Net shares
−12.84K
Net value
-$895.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/29/2026 | G · Gift | −300K | — | — | 10.4% | 2.88M | 2.58M |
| Common Stock Indirect | 5/29/2026 | G · Gift | +150K | — | — | New position | 0.00 | 150K |
| Common Stock Indirect | 5/29/2026 | G · Gift | +150K | — | — | New position | 0.00 | 150K |
| Common Stock Indirect | 6/1/2026 | S · Sale | −12.84K | $69.74 | $895.25K | 0.5% | 2.58M | 2.57M |
| Total | −12.84K | -$895.25K | ||||||
Derivative Transactions0
No derivative transactions reported